Skip to main content
. 2017 Sep 18;4(5):ENEURO.0211-17.2017. doi: 10.1523/ENEURO.0211-17.2017

Figure 3.

Figure 3.

EBR and [18F]fallypride BPND. EBR in the placebo condition did not significantly correlate with [18F]fallypride BPND in the caudate (t15 = –0.67, p = 0.512), putamen (t15 = –0.76, p = 0.461), ventral striatum (t15 = 0.95, p = 0.356), or midbrain (t15 = 0.14, p = 0.890).